Please assess the completion status of the following clinical trial:

Trial Title: Endoscopic Peroral Myotomy for Treatment of Achalasia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Patient with symptomatic achalasia and pre-op barium swallow, manometry and esophagal-gastro-duodenoscopy which are consistent with the diagnosis~* persons of age \> 18 years with medical indication for surgical myotomy or Endoscopic balloon dilatation~* Signed written informed consent.~Exclusion criteria:~* Patients with previous surgery of the stomach or esophagus~* Patients with known coagulopathy~* Previous achalasia-treatment with surgery~* Patients with liver cirrhosis and/or esophageal varices~* Active esophagitis~* Eosinophilic esophagitis~* Barrett's esophagus~* Pregnancy~* Stricture of the esophagus~* Malignant or premalignant esophageal lesion~* Candida esophagitis~* Hiatal hernia \> 2cm

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Peroral Endoscopic Myotomy (Type: EXPERIMENTAL): Patients with achalasia who are designed to either get balloon dilatation or have botulinum toxin injection, or to have surgical intervention (Heller myotomy)for treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).